Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial

Prasad Rao Gundugurti, Nagaraju Banda, Siva Sankara Rao Yadlapalli, Arjun Narala, Ramyasree Thatikonda, Chandrashekhar Kocherlakota, Kumar S.D. Kothapalli

2024Asian Journal of Psychiatry21 citationsDOI

Topics & Concepts

PlaceboDouble blindMedicinePharmacokineticsAnxietyCannabidiolRandomized controlled trialClinical trialMulticenter studyPharmacologyInternal medicinePsychiatryAlternative medicineCannabisPathologyCannabis and Cannabinoid ResearchPain Management and Placebo EffectPsychedelics and Drug Studies

Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial

Topics & Concepts

Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial